Search Within

Gary Schwartz

  1. "Population Sciences Research Program"
Formats
  1. Meeting Abstract (13)
  2. Journal Article (11)
Groups
  1. Population Sciences Research Program (24)
  2. GSK Faculty (19)
  3. Department of Medicine (18)
  4. Solid Tumor Oncology Division (18)
  5. Epidemiology and Biostatistics (16)
  6. Biostatistics Service (15)

More Groups

People
  1. Katherine Panageas (14)
  2. Richard Carvajal (14)
  3. Jedd Wolchok (13)
  4. Paul Chapman (13)
  5. Yueming Li (6)
  6. Christopher Shelton (5)

More People

Years
  1. 2016 (1)
  2. 2014 (2)
  3. 2013 (7)
  4. 2012 (2)
  5. 2011 (2)
  6. 2010 (2)

More Years

Publications
  1. Journal of Clinical Oncology (8)
  2. Cancer Research (7)
  3. Clinical Cancer Research (2)
  4. JAMA - Journal of the American Medical Association (2)
  5. Annals of Oncology (1)
  6. Cancer (1)

More Publications

Publishers
  1. American Association for Cancer Research (9)
  2. American Society of Clinical Oncology (8)
  3. American Medical Association (2)
  4. Oxford University Press (2)
  5. Biomed Central Ltd (1)
  6. Springer (1)

More Publishers

Results (24)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Evaluation of the absolute lymphocyte count as a biomarker for melanoma patients treated with the commercially available dose of ipilimumab (3mg/kg)
    Meeting Abstract

    Postow, M. A.; Yuan, J.; Panageas, K.; Bogatch, K.; Callahan, M.; Cheng, M.; Schroeder, S. E. A.; Kendle, R. F.; Harding, J. J.; Dickson, M. A.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Pharmacodynamic activity of selumetinib to predict radiographic response in advanced uveal melanoma
    Meeting Abstract

    Carvajal, R. D.; Ambrosini, G.; Wolchok, J. D.; Chapman, P. B.; Dickson, M. A.; D'Angelo, S. P.; Bluth, M. J.; Paucar, D.; Fusco, A.; Bohr, D.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • PTEN is a critical determinant in sensitizing cells to gamma-secretase inhibitors
    Meeting Abstract

    Nair, J. S.; Sheikh, T. N.; Li, Y. M.; Schwartz, G. K.
    Cancer Research (2011)

    Fulltext@MSK | Save
  • KIT as a therapeutic target in metastatic melanoma
    Journal Article

    Carvajal, R. D.; Antonescu, C. R.; Wolchok, J. D.; Chapman, P. B.; Roman, R. A.; Teitcher, J.; Panageas, K. S.; Busam, K. J.; Chmielowski, B.; Lutzky, J.; more...
    JAMA - Journal of the American Medical Association (2011)

    Fulltext@MSK | Save
  • Single-institution experience with ipilimumab in advanced melanoma patients in the compassionate use setting lymphocyte count after 2 doses correlates with survival
    Journal Article

    Ku, G. Y.; Yuan, J.; Page, D. B.; Schroeder, S. E. A.; Panageas, K. S.; Carvajal, R. D.; Chapman, P. B.; Schwartz, G. K.; Allison, J. P.; Wolchok, J. D.
    Cancer (2010)

    Fulltext@MSK | Save
  • Immunologic response to xenogeneic gp100 DNA in melanoma patients: Comparison of particle-mediated epidermal delivery with intramuscular injection
    Journal Article

    Ginsberg, B. A.; Gallardo, H. F.; Rasalan, T. S.; Adamow, M.; Mu, Z.; Tandon, S.; Bewkes, B. B.; Roman, R. A.; Chapman, P. B.; Schwartz, G. K.; more...
    Clinical Cancer Research (2010)

    Fulltext@MSK | Save
  • Suppression of notch signaling with gamma-secretase inhibitors sensitizes malignant peripheral nerve sheath tumors to inhibitors of the Ras/Raf and PI3K/Akt pathways
    Meeting Abstract

    Meng, R. D.; Shelton, C. C.; Li, Y.; Schwartz, G. K.
    Cancer Research (2009)

    Fulltext@MSK | Save
  • Phase i trial of weekly cisplatin, irinotecan and paclitaxel in patients with advanced gastrointestinal cancer
    Journal Article

    Tew, W. P.; Radovich, D.; O'reilly, E.; Schwartz, G.; Schrag, D.; Saltz, L. B.; Kelsen, D. P.; Kepler, S.; Ilson, D. H.
    Investigational New Drugs (2009)

    Fulltext@MSK | Save
  • γ-secretase inhibitors abrogate oxaliplatin-induced activation of the Notch-1 signaling pathway in colon cancer cells resulting in enhanced chemosensitivity
    Journal Article

    Meng, R. D.; Shelton, C. C.; Li, Y. M.; Qin, L. X.; Notterman, D.; Paty, P. B.; Schwartz, G. K.
    Cancer Research (2009)

    Fulltext@MSK | Save
  • Dual inhibition of the Notch and Hedgehog developmental pathways in colon cancers suppresses viability by combined downregulation of the PI3K/Akt pathway
    Meeting Abstract

    Meng, R. D.; Shelton, C. C.; Li, Y. M.; Schwartz, G. K.
    Cancer Research (2008)

    Fulltext@MSK | Save